Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction

Christian Gratzke, MD, Javier Angulo, PhD, Kanchan Chitaley, PhD, Yu-tian Dai, MD, PhD, Noel N. Kim, PhD, Jaw-Seung Paick, MD, PhD, Ulf Simonsen, MD, PhD, Stefan Ückert, PhD, Eric Wespes, MD, PhD, Karl E. Andersson, MD, PhD, Tom F. Lue, MD, and Christian G. Stief, MD, PhD

Correction for The Journal of Sexual Medicine2010;7(1):445–75.

There are two corrections for this article. The image included for Figure 2 on page 461 is incorrect. The image that should have appeared is below:

β-adrenoceptor antagonists and erectile function. Propranolol is a general β-adrenoceptor antagonist, while carvedilol and labetalol also block α1-adrenoceptors. Metoprolol, bisoprolol, and atenolol are selective β1-adrenoceptor antagonists, and nebivolol, in addition, leads to release of nitric oxide (NO).
Figure 2

β-adrenoceptor antagonists and erectile function. Propranolol is a general β-adrenoceptor antagonist, while carvedilol and labetalol also block α1-adrenoceptors. Metoprolol, bisoprolol, and atenolol are selective β1-adrenoceptor antagonists, and nebivolol, in addition, leads to release of nitric oxide (NO).

Also, Dr. Angulo’s affiliation was listed incorrectly. It should have appeared as, “Departamento de Investigación, Hospital Ramón y Cajal, Madrid, Spain.”